Fiduciary Financial Group’s Gilead Sciences GILD Stock Holding History

Fiduciary Financial Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$226K	Buy	+1,785	New	+$235K	0.03%	352

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Fiduciary Financial Group's GILD Position: Q2 2026 in Review

Fiduciary Financial Group opened a new position in Gilead Sciences (GILD) in Q2 2026: 1,785 shares worth $226K. The stake represents 0.03% of the portfolio and ranks #352 among its holdings.

1,014 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Fiduciary Financial Group held 1,785 shares of Gilead Sciences worth $226K as of Q2 2026.
Gilead Sciences was a new Fiduciary Financial Group position in Q2 2026.
Gilead Sciences made up 0.03% of Fiduciary Financial Group's portfolio in Q2 2026, its #352 holding.
1,014 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Fiduciary Financial Group's 13F filing for Q2 2026, filed 10 Jul 2026.